Metabolic dysfunction–associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study

BACKGROUND AND AIMS: Recently metabolic dysfunction–associated fatty liver disease (MAFLD) has been introduced and was defined as hepatic steatosis with either overweight, diabetes, and/or a combination of other metabolic risk factors. We investigated the application of the MAFLD criteria as compare...

Descripción completa

Detalles Bibliográficos
Autores principales: van Kleef, Laurens A., Ayada, Ibrahim, Alferink, Louise J.M., Pan, Qiuwei, de Knegt, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299928/
https://www.ncbi.nlm.nih.gov/pubmed/34453359
http://dx.doi.org/10.1002/hep.32131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299928/
https://www.ncbi.nlm.nih.gov/pubmed/34453359
http://dx.doi.org/10.1002/hep.32131

Ejemplares similares